Patents by Inventor Kelly Tanaka

Kelly Tanaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for engraftment and increasing survival of adult muscle stem cells
    Patent number: 8992906
    Abstract: Embodiments herein relate to compositions and methods for engraftment of and increasing survival of muscle cells in a subject in need thereof. In certain embodiments, compositions including myofibers and/or satellite stem cells may be administered to a subject. Other embodiments relate to compositions and methods for introducing one or more compounds to a subject using cell compositions disclosed herein. Still other embodiments relate to uses of these compositions in kits for portable applications and methods.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: March 31, 2015
    Assignee: The Regents of the University of Colorado, a body corporate
    Inventors: Bradley Bruce Olwin, John K. Hall, Kathleen Kelly Tanaka
  • Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections
    Patent number: 8946144
    Abstract: The present invention is directed to antimicrobial compounds which have an affinity for binding bones. More particularly, the invention is directed to phosphonated derivatives of glycopeptide or lipoglycopeptide antibiotics. These compounds are useful as antibiotics for the prevention or treatment of bone and joint infections, especially for the prevention and treatment of osteomyelitis.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: February 3, 2015
    Assignee: The Medicines Company
    Inventors: Kelly Tanaka, Stephane Ciblat, Adel Rafai Far, Evelyne Dietrich
  • Glycopeptide and lipoglycopeptide antibiotics with improved solubility
    Patent number: 8901072
    Abstract: The invention relates to derivatives of glycopeptide and lipoglycopeptide antibiotics possessing an altered ionization state with respect to the parent glycopeptide or lipoglycopeptide antibiotic, and having the ability to be regenerated as the parent glycopeptide or lipoglycopeptide antibiotic under physiological conditions. These compounds are useful as antibiotics for the prevention and/or the treatment of bacterial infections.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: December 2, 2014
    Assignee: The Medicines Company
    Inventors: Adel Rafai Far, Kelly Tanaka, Evelyne Dietrich, Ranga Reddy, Ting Kang
  • Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
    Patent number: 8524691
    Abstract: The present invention relates to phosphonated Rifamycins, and methods of making and using such compounds. These compounds are useful as antibiotics for prophylaxis and/or the treatment of bone and joint infections, especially for the prophylaxis and/or treatment of osteomyelitis.
    Type: Grant
    Filed: August 10, 2009
    Date of Patent: September 3, 2013
    Assignee: The Medicines Company
    Inventors: Evelyne Dietrich, Ranga Reddy, Kelly Tanaka, Ting Kang, Yanick LaFontaine, Adel Rafai Far
  • GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS WITH IMPROVED SOLUBILITY
    Publication number: 20120149632
    Abstract: The invention relates to derivatives of glycopeptide and lipoglycopeptide antibiotics possessing an altered ionization state with respect to the parent glycopeptide or lipoglycopeptide antibiotic, and having the ability to be regenerated as the parent glycopeptide or lipoglycopeptide antibiotic under physiological conditions. These compounds are useful as antibiotics for the prevention and/or the treatment of bacterial infections.
    Type: Application
    Filed: August 11, 2010
    Publication date: June 14, 2012
    Applicant: THE MEDICINES COMPANY
    Inventors: Adel Rafai Far, Kelly Tanaka, Evelyne Dietrich, Ranga Reddy, Ting Kang
  • PHOSPHONATED RIFAMYCINS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
    Publication number: 20110178001
    Abstract: The present invention relates to phosphonated Rifamycins, and methods of making and using such compounds. These compounds are useful as antibiotics for prophylaxis and/or the treatment of bone and joint infections, especially for the prophylaxis and/or treatment of osteomyelitis.
    Type: Application
    Filed: August 10, 2009
    Publication date: July 21, 2011
    Applicant: TARGANTA THERAPEUTICS CORP.
    Inventors: Evelyne Dietrich, Ranga Reddy, Kelly Tanaka, Ting Kang, Yanick Lafontaine, Adel Rafai Far
  • COMPOSITIONS AND METHODS FOR ENGRAFTMENT AND INCREASING SURVIVAL OF ADULT MUSCLE STEM CELLS
    Publication number: 20100226898
    Abstract: Embodiments herein relate to compositions and methods for engraftment of and increasing survival of muscle cells in a subject in need thereof. In certain embodiments, compositions including myofibers and/or satellite stem cells may be administered to a subject. Other embodiments relate to compositions and methods for introducing one or more compounds to a subject using cell compositions disclosed herein. Still other embodiments relate to uses of these compositions in kits for portable applications and methods.
    Type: Application
    Filed: April 11, 2008
    Publication date: September 9, 2010
    Inventors: Bradley Bruce Olwin, John K. Hall, Kathleen Kelly Tanaka
  • PHOSPHONATED GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
    Publication number: 20100113333
    Abstract: The present invention is directed to antimicrobial compounds which have an affinity for binding bones. More particularly, the invention is directed to phosphonated derivatives of glycopeptide or lipoglycopeptide antibiotics. These compounds are useful as antibiotics for the prevention or treatment of bone and joint infections, especially for the prevention and treatment of osteomyelitis.
    Type: Application
    Filed: December 21, 2007
    Publication date: May 6, 2010
    Applicant: TARGANTA THERAPEUTICS, INC.
    Inventors: Kelly Tanaka, Adel Rafai Far, Stephane Ciblat, Evelyne Dietrich
  • Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections
    Publication number: 20080287396
    Abstract: The present invention relates to phosphonated fluoroquinolones, antibacterial analogs thereof, and methods of using such compounds. These compounds are useful as antibiotics for prevention and/or the treatment of bone and joint infections, especially for the prevention and/or treatment of osteomyelitis.
    Type: Application
    Filed: April 21, 2006
    Publication date: November 20, 2008
    Applicant: TARGANTA THERAPEUTICA INC.
    Inventors: Daniel Delorme, Tom Houghton, Ting Kang, Kelly Tanaka, Yanick LaFontaine, Evelyne Dietrich, Adel Rafai Far